Viewing Study NCT00121602


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-03-09 @ 4:14 AM
Study NCT ID: NCT00121602
Status: COMPLETED
Last Update Posted: 2008-02-28
First Post: 2005-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia View
None Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hemodialysis View
None Darbepoetin Alfa View
None Clinical Trials View
None Nephrology View
None Amgen View
None Chronic Kidney Disease (CKD) View